
pmid: 6491238
Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening complication of neuroleptic therapy. Its occurrence is not familiar to most emergency physicians. Early recognition and appropriate management of NMS may prevent significant morbidity and mortality.
Dose-Response Relationship, Drug, Loxapine, Middle Aged, Trihexyphenidyl, Diagnosis, Differential, Basal Ganglia Diseases, Chronic Disease, Dibenzoxazepines, Schizophrenia, Humans, Neuroleptic Malignant Syndrome, Drug Therapy, Combination, Female, Emergencies
Dose-Response Relationship, Drug, Loxapine, Middle Aged, Trihexyphenidyl, Diagnosis, Differential, Basal Ganglia Diseases, Chronic Disease, Dibenzoxazepines, Schizophrenia, Humans, Neuroleptic Malignant Syndrome, Drug Therapy, Combination, Female, Emergencies
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
